Dmitry Zamansky Sells 5,575 Shares of American Well (NYSE:AMWL) Stock

American Well Corporation (NYSE:AMWL) insider Dmitry Zamansky sold 5,575 shares of the firm’s stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $5.30, for a total value of $29,547.50. Following the transaction, the insider directly owned 241,080 shares of the company’s stock, valued at $1,277,724. This represents a 2.26% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Dmitry Zamansky also recently made the following trade(s):

• On Friday, January 2nd, Dmitry Zamansky sold 6,243 shares of American Well stock. The stock was sold at an average price of $4.85, for a total transaction of $30,278.55.

American Well Price Performance

Shares of American Well stock opened at $5.51 on Friday. The company has a 50-day moving average of $5.23 and a 200 day moving average of $5.08. The firm has a market cap of $91.11 million, a price-to-earnings ratio of -0.93 and a beta of 1.39. American Well Corporation has a 1 year low of $3.71 and a 1 year high of $9.15.

American Well (NYSE:AMWL) last posted its quarterly earnings data on Thursday, February 12th. The company reported ($1.52) EPS for the quarter, topping the consensus estimate of ($1.59) by $0.07. The business had revenue of $55.31 million for the quarter, compared to analyst estimates of $52.71 million. American Well had a negative net margin of 38.38% and a negative return on equity of 35.33%. On average, equities analysts anticipate that American Well Corporation will post -9.34 EPS for the current year.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the company. Weiss Ratings restated a “sell (e+)” rating on shares of American Well in a research note on Wednesday, January 21st. Stifel Nicolaus lowered their price objective on American Well from $6.00 to $5.00 and set a “hold” rating for the company in a research note on Friday, February 13th. Morgan Stanley dropped their target price on American Well from $10.50 to $6.00 and set an “equal weight” rating on the stock in a report on Thursday, December 18th. Finally, Wall Street Zen raised American Well from a “sell” rating to a “hold” rating in a research note on Sunday, March 22nd. One equities research analyst has rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $7.42.

Institutional Investors Weigh In On American Well

Several institutional investors and hedge funds have recently made changes to their positions in AMWL. Headlands Technologies LLC bought a new position in American Well in the 2nd quarter valued at approximately $39,000. Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in shares of American Well in the 3rd quarter worth $62,000. Occudo Quantitative Strategies LP bought a new stake in shares of American Well in the 4th quarter worth $74,000. NewEdge Advisors LLC purchased a new position in shares of American Well in the fourth quarter worth $82,000. Finally, Prelude Capital Management LLC purchased a new position in shares of American Well in the third quarter worth $86,000. Institutional investors own 56.05% of the company’s stock.

American Well Company Profile

American Well, operating under the trade name Amwell, is a Boston-based digital health company that develops and delivers telehealth solutions to healthcare providers, payers, employers and patients. Through its cloud-based platform, the company enables secure virtual visits, remote patient monitoring and integrated care coordination across a range of medical disciplines, including primary care, behavioral health, chronic disease management and urgent care.

The company’s core offering, the Amwell Telehealth Platform, facilitates live video consultations, asynchronous messaging, e-prescribing and electronic health record integration.